Esperion Therapeutics Announces the Appointment of Scott Braunstein, M.D. to Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Esperion Therapeutics (ESPR) Adds Scott Braunstein, M.D., as Director
June 15, 2015 8:31 AM EDTEsperion Therapeutics (NASDAQ: ESPR) announced the appointment of Scott Braunstein, M.D. as a Class III Director, with a term expiring at the 2016 annual meeting of stockholders.
"I'm very pleased to welcome Dr. Braunstein to the Esperion board," said Tim Mayleben, president and chief executive officer. "With an experience base which spans the healthcare sector -- first as a practicing physician and... More
